FINN Partners Lands AD/PD™ Conference PR Mandate Ahead of 2027 Event
Event summary
- FINN Partners named Global PR Agency of Record for AD/PD™ Conference, effective immediately ahead of the 2027 event.
- AD/PD™ 2027 conference scheduled for March 16–20, 2027 in Barcelona, Spain as a hybrid event.
- FINN to leverage its 38-office global network and specialized brain health practice for the engagement.
- 2026 conference attracted 6,000 attendees from 70+ countries.
- FINN's selection underscores its position as a leading global health communications agency.
The big picture
This partnership comes as neurodegenerative disease research gains urgency amid an aging global population. FINN's selection reflects the growing importance of specialized communications in scientific conferences, particularly those bridging basic research with clinical applications. The engagement also highlights FINN's strategic expansion in the brain health sector, complementing its existing work with biotech and pharma clients.
What we're watching
- Conference Growth
- Whether FINN can significantly expand AD/PD™'s international footprint and delegate participation beyond the 2026 numbers.
- Scientific Impact
- How effectively FINN can position AD/PD™ as the premier venue for translational neuroscience breakthroughs.
- Strategic Alignment
- The pace at which FINN integrates its global health practice capabilities with AD/PD™'s scientific mission.